Experimental models and mechanisms underlying the protective effects of n-3 polyunsaturated fatty acids in Alzheimer's disease

J Nutr Biochem. 2009 Jan;20(1):1-10. doi: 10.1016/j.jnutbio.2008.05.016. Epub 2008 Sep 27.

Abstract

Dementia such as Alzheimer's disease (AD) is a growing health problem in aging populations in many countries around the world. Currently, there is no cure for AD; consequently, alternative therapies are urgently needed. Recent studies suggest that nutritional intervention may have therapeutic benefits for AD. Specifically, an increased intake of n-3 polyunsaturated fatty acids (PUFA) from fish and marine oils may lower AD risk. This review will summarize the current body of knowledge regarding the association between n-3 PUFA and AD, including human studies and experimental models, and potential mechanisms of action.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Aging
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / therapy
  • Animals
  • Brain / metabolism
  • Cells, Cultured
  • Diet
  • Disease Models, Animal
  • Fatty Acids, Omega-3 / metabolism*
  • Fish Oils
  • Humans
  • Membrane Microdomains / chemistry
  • Mice
  • Rats
  • Risk

Substances

  • Fatty Acids, Omega-3
  • Fish Oils